Try our beta test site

The Ribavirin Pregnancy Registry (RPR)

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2017 by INC Research
Aurobindo Pharma
Genentech, Inc.
Merck Sharp & Dohme Corp.
Teva Pharmaceuticals USA
Zydus Pharmaceuticals USA, Inc.
Kadmon Pharmaceuticals
Information provided by (Responsible Party):
INC Research Identifier:
First received: June 16, 2005
Last updated: January 23, 2017
Last verified: January 2017
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2025
  Estimated Primary Completion Date: December 2024 (Final data collection date for primary outcome measure)